TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+2.9%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.56B
AUM Growth
-$71.2M
(-2.7%)
Cap. Flow
-$98.7M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
186
New
9
Increased
27
Reduced
32
Closed
20
Top Buys
| 1 |
Merck
MRK
|
$20.3M |
| 2 |
Amgen
AMGN
|
$13.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$13.2M |
| 4 |
Insulet
PODD
|
$12.6M |
| 5 |
Tenet Healthcare
THC
|
$12.1M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$35.4M |
| 2 |
Cigna
CI
|
$24.2M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$21.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
$13.1M |
| 5 |
UnitedHealth
UNH
|
$13.1M |
Sector Composition
| 1 | Healthcare | 96.11% |
| 2 | Real Estate | 2.09% |
| 3 | Industrials | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Merus
MRUS
$5.01B
| – | – |
-69,025
| Closed | -$1.27M |
|
177
Option Care Health
OPCH
$4.67B
| – | – |
-64,975
| Closed | -$2.06M |
|
178
Ultragenyx Pharmaceutical
RARE
$3.01B
| – | – |
-67,065
| Closed | -$2.69M |
|
179
Syndax Pharmaceuticals
SNDX
$1.39B
| – | – |
-117,717
| Closed | -$2.49M |
|
180
Travere Therapeutics
TVTX
$1.89B
| – | – |
-418,520
| Closed | -$9.41M |
|
181
Zai Lab
ZLAB
$3.34B
| – | – |
-34,640
| Closed | -$1.15M |
|
|
CTLT
182
DELISTED
CATALENT, INC.
CTLT
| – | – |
-49,406
| Closed | -$3.25M |
|
|
VECT
183
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| – | – |
-682,834
| Closed | -$5.87M |
|
|
RXDX
184
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – |
-50,538
| Closed | -$5.42M |
|
|
CSII
185
DELISTED
Cardiovascular Systems, Inc.
CSII
| – | – |
-174,859
| Closed | -$3.47M |
|